The Safety Management of Cardiac Toxicity in Breast Cancer Patients Under Multidiscipline Therapy.

NAActive, not recruitingINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

June 27, 2017

Primary Completion Date

October 8, 2020

Study Completion Date

October 31, 2025

Conditions
Breast NeoplasmsCardiotoxicity
Interventions
OTHER

limit heart dose

limit heart dose: Dmean≤6Gy,V30≤20%,V10≤50%

Trial Locations (1)

200025

Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai

All Listed Sponsors
collaborator

RenJi Hospital

OTHER

collaborator

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

OTHER

collaborator

Shanghai 6th People's Hospital

OTHER

collaborator

Shanghai 10th People's Hospital

OTHER

lead

Ruijin Hospital

OTHER

NCT02942615 - The Safety Management of Cardiac Toxicity in Breast Cancer Patients Under Multidiscipline Therapy. | Biotech Hunter | Biotech Hunter